Chris Bahl
Researcher · Founder
Now Founder, AI Proteins
Latest on AI4S.fyiTimeline · Oct 21Astellas signs AI Proteins to design miniprotein drugs against its targets, in a deal worth more than $400M with milestonesPhotos come from each person's X account, their own site, lab or team page, a conference page that lists them as a speaker in the same role, or Wikimedia Commons under the licence credited, so some may be out of date. Anyone can ask for theirs to be replaced or removed. Contact →
Affiliations
Current
- Founder · AI Proteins
Also named in the companies' announcements: Baker lab / IPD, Harvard
Current roles come from these dated records, not from the bio below. Each links the page it was read from.
Founded
AI ProteinsProtein design · 1 round on record · disclosed $41.5M · Series A $41.5MBackground: Institute for Protein Innovation, Boston (founding faculty), with appointments at Boston Children's Hospital and Harvard Medical School; postdoc with David Baker at the Institute for Protein Design (as the company's own announcements put it)
Backed byMission BioCapitalSanté Ventures
On the timeline
- 2026-10-21Astellas signs AI Proteins to design miniprotein drugs against its targets, in a deal worth more than $400M with milestones
- 2026-08-05AI Proteins publishes the lab workflow that turns DNA into purified protein in three days, and made 87 of 96 test proteins with it
- 2025-11-20AI Proteins raises a $41.5M Series A for AI-designed miniprotein drugs, and will spin programs out as subsidiaries
Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →